Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Medical Diagnostics|March 14, 2013
Bioinformatics advances for clinical biomarker developmentKenneth Ph Pritzker, Laura B Pritzker
BMC Cancer|February 26, 2016
RNA disruption is associated with response to multiple classes of chemotherapy drugs in tumor cell linesRashmi Narendrula, Kyle Mispel-Beyer, Baoqing Guo, et al.
Endocrine-Related Cancer|May 10, 2014
Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenograftsAnton Neschadim, Laura B Pritzker, Kenneth P H Pritzker, et al.
Breast Cancer Research and Treatment|July 26, 2015
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapyAmadeo M Parissenti, Baoqing Guo, Laura B Pritzker, et al.
Scientific Reports|May 28, 2020
The RNA disruption assay is superior to conventional drug sensitivity assays in detecting cytotoxic drugsJonathan P J Mapletoft, Renée J St-Onge, Baoqing Guo, et al.
Scientific Reports|January 31, 2023
RNA disruption is a widespread phenomenon associated with stress-induced cell death in tumour cellsPhillipe Butler, Isabella Pascheto, Michayla Lizzi, et al.
Cancers|September 13, 2025
Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical UtilityAmadeo M Parissenti, Sanaa Noubir, Laura B Pritzker, et al.
BMC Veterinary Research|December 18, 2019
RNA disruption indicates CHOP therapy efficacy in canine lymphomaAmadeo M Parissenti, Laura B Pritzker, Baoqing Guo, et al.
Pageof 1